Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chemotherapy
Studies from Center for Urban Health Policy and Research provide new data on chemotherapy
January 17th, 2009
Data detailed in 'The importance of patient participation in second-line chemotherapy decisions: perspectives of African-American patients' have been presented. "Minority populations have been considered to be less-active participants in their health and, consequently, more vulnerable to having decisions made for them. PROCEDURES: We interviewed African-American patients (N=26) with cancer who had recently consented to second-line chemotherapy, offered when their disease was no longer responding to standard first-line regimen," scientists writing in the Journal of the National Medical Association report. "The majority (73%) reported involvement in the decision to...
Source: Law & Health Weekly (2009-01-17)
|
